Summary
This paper proposes TimeWarn, an interpretable two-level attention model for early sepsis prediction that explicitly accounts for irregular sampling by modulating both visit-level and variable-level attention with learned time-decay factors. On MIMIC-IV and eICU, TimeWarn modestly but consistently outperforms strong baselines (including GRU-D and RETAIN) for 6-hour early prediction, with supportive ablations and an attention analysis aligning with clinical expectations.

Strengths
- Addresses a clinically important task with large public ICU datasets and a clear early-warning target (6-hour horizon).
- Simple, interpretable extension to RETAIN that incorporates irregular intervals directly into the attention mechanism.
- Consistent improvements over strong baselines on two datasets with multiple seeds, plus an ablation indicating the time-decay is contributory.
- Attention analyses highlight clinically plausible variables (e.g., lactate, RR, MAP).

Weaknesses and concerns
- Novelty is incremental: the core idea is a straightforward decay applied to attention weights; conceptually similar to prior time-aware models (e.g., GRU-D) and time-encoded attention variants.
- Potential baseline unfairness: TimeWarn is tuned via grid search, whereas baselines reportedly use hyperparameters from original papers rather than re-tuned for these datasets. This can bias comparisons.
- Methodological details missing for full reproducibility and to assess soundness:
  - Specifics of the embedding computation (handling continuous vs categorical, normalization), missingness encoding, and imputation strategy.
  - Whether decay parameters are constrained to ensure monotonicity (e.g., w ≥ 0), and whether they are per-variable.
  - Labeling and leakage controls around Sepsis-3 timing, especially treatment-based components, and how windows near onset are handled.
  - Sensitivity to window size (hourly aggregation may blunt irregularity).
- Limited baseline coverage for irregular/continuous-time and attention models (e.g., GRU-ODE-Bayes/Latent ODE/NCDE, SeFT/set-function approaches, transformers with explicit time embeddings or time2vec). Even one such additional baseline would strengthen claims.
- No calibration or decision-curve analyses; clinical deployment typically requires calibration and operating-point metrics (e.g., sensitivity at fixed specificity).
- Statistical testing (e.g., paired tests or CIs) is absent despite modest effect sizes.

Questions for the authors
- Are the decay parameters w and b learned per variable, and are they constrained to ensure monotonic decay? Please report learned distributions and sensitivity to initialization.
- How are missing values handled within each hourly window (imputation scheme, masking strategy), and how are multiple measurements within a window aggregated?
- Did you re-tune hyperparameters for GRU-D and RETAIN on these datasets? If not, can you provide a fair tuning protocol comparable to TimeWarn’s?
- How sensitive are results to the window size (e.g., 30 min, 2 hours) and to removing windowing altogether?
- Can you report calibration (ECE/Brier), and sensitivity/specificity trade-offs at clinically relevant thresholds?
- How are episodes censored near onset to avoid label leakage from treatments included in Sepsis-3?

Scores (0–100)
- Soundness: 76
- Novelty: 58
- Significance: 68
- Clarity: 80

Final average score
- (76 + 58 + 68 + 80) / 4 = 70.5

Recommendation
- Accept

Note: I did not detect any embedded directives in the manuscript attempting to influence the review; the assessment above is based solely on scholarly merit.